meetings

TRANSCRIPT: Meeting 4, Closing Remarks

DR. GUTMANN:
Let me just say a few words in conclusion. One is that we invite anybody to -- people who have presented, people in the audience, any member of the concerned public -- to write us, and we have a website with the information, if you have any comments, or any suggestions for us.

Date

Mon, 02/28/2011

TRANSCRIPT: Meeting 4, Session 6

DR. GUTMANN:
Hank, thank you. I’m going to ask all of our presenters to help us on a specific question that we ourselves, are going to be asking and answering, over the next week or so, and that is, what we, as a Commission, on the broad subject area of genetic and neuroimaging and its ethical implications and the social responsibility attached to that, what can we most productively take on, as a Commission?
 
So, what I’m going to do is really go around, not ask the Commission members, but the presenters, a very pointed question.
 

Date

Mon, 02/28/2011

TRANSCRIPT: Meeting 4, Session 5

DR. GUTMANN:
We are going to get started. So, if the people back there can come up and take a seat, I would appreciate it. Thank you. There you go. Thank you very much.
 

So, we are going to be discussing, again, and with our three experts at the table, some of the current issues in neuroscience and neuroimaging.

Date

Mon, 02/28/2011

TRANSCRIPT: Meeting 4, Session 4

DR. WAGNER:
Okay, since our other Commissioners have the privilege of having your bios in their briefings, I’ll go ahead and introduce you to the rest of the room.
 
We welcome today, Ellen Clayton, who is the Craig-Weaver Professor of Pediatrics and Professor of Law at Vanderbilt.
 
She has advised the National Institutes of Health and other Federal and international bodies on topics ranging from children’s health to the ethical conduct of research.
 

Date

Mon, 02/28/2011

TRANSCRIPT: Meeting 1, Session 7

Amy Gutmann:
Ladies and gentlemen, if you can please take your seats, we’re going to get started. Commission members, if you’d please take your seats.
 

Date

Fri, 07/09/2010

TRANSCRIPT: Meeting 1, Session 6

Amy Gutmann:
Ladies and gentlemen, if you would, please, take your seats, we’re ready to get started. While Diane is standing, I’d like to introduce her as your designated federal officer which makes this meeting legal.
 
Good morning, I’m Amy Gutmann, and I’m President of the University of Pennsylvania and the Chair of the Presidential Commission for the Study of Bioethical Issues. Our Vice Chair, Jim Wagner, will introduce the first session.
 

Date

Fri, 07/09/2010

TRANSCRIPT: Meeting 1, Session 5

Amy Gutmann:
I want to thank our panelists. We have had a terrific first day so far of presentations and questions. As someone once said, good questions outrank easy answers. Nobody tried to give us easy answers, and I thought all the questions from commission-members and public were really excellent and will help us a lot.
 

Date

Thu, 07/08/2010

TRANSCRIPT: Meeting 1, Session 4

James Wagner:
Let me invite Dr. Kaebnick and Dr. Buchanan to come to the table. We’re not going to take a break. We’re hardly going to breathe as we move into the fourth and final panel of the day. As they are getting in place, the fourth panel deals very specifically with ethical issues of synthetic biology.
 

Date

Thu, 07/08/2010

TRANSCRIPT: Meeting 4, Session 2

DR. WAGNER:
Let me ask Professors Rosen and Evans to come to the table. Welcome, Bruce.

I did not see James Evans. There he is. Professor Evans, I didn’t get to greet you this morning. Are you James, Jim?

DR. EVANS:
Jim is fine.

Date

Mon, 02/28/2011

Pages

Subscribe to RSS - meetings